MONTPELLIER, France–(BUSINESS WIRE)–MedinCell (Paris: MEDCL): Access the complete press release About MedinCell MedinCell is a clinical stage pharmaceutical company that develops a portfolio of long-acting injectable products in various therapeutic areas by combining its proprietary BEPO® technology with active ingredients already known and marketed. Through the controlled and extended release of the active pharmaceutical ingredient, MedinCell makes medical treatments more efficient, particul
Source link
